TreeWAS – Variant ID: rs6952808

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
N42.8 Other specified disorders of prostate	0.000	0.954	0.046
O04.9 Complete or unspecified, without complication	0.029	0.971	0.000
O04 Medical abortion	0.022	0.978	0.000
K14.8 Other diseases of tongue	0.000	0.980	0.020
O04.4 Incomplete, without complication	0.019	0.981	0.000
O04.1 Incomplete, complicated by delayed or excessive haemorrhage	0.017	0.983	0.000
O04.8 Complete or unspecified, with other and unspecified complications	0.016	0.984	0.000
O04.7 Complete or unspecified, complicated by embolism	0.016	0.984	0.000
O04.6 Complete or unspecified, complicated by delayed or excessive haemorrhage	0.016	0.984	0.000
O04.5 Complete or unspecified, complicated by genital tract and pelvic infection	0.016	0.984	0.000
O04.3 Incomplete, with other and unspecified complications	0.016	0.984	0.000
O04.2 Incomplete, complicated by embolism	0.016	0.984	0.000
O04.0 Incomplete, complicated by genital tract and pelvic infection	0.016	0.984	0.000
C22.9 Liver, unspecified	0.015	0.985	0.000
C22.1 Intrahepatic bile duct carcinoma	0.015	0.985	0.000
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.014	0.986	0.000
C22.0 Liver cell carcinoma	0.012	0.988	0.000
E11.5 With peripheral circulatory complications	0.011	0.989	0.000
E11.4 With neurological complications	0.011	0.989	0.000
C44.4 Skin of scalp and neck	0.011	0.989	0.000
N28.8 Other specified disorders of kidney and ureter	0.010	0.990	0.000
C22.7 Other specified carcinomas of liver	0.010	0.990	0.000
C22.4 Other sarcomas of liver	0.010	0.990	0.000
C22.3 Angiosarcoma of liver	0.010	0.990	0.000
C22.2 Hepatoblastoma	0.010	0.990	0.000
E11 Non-insulin-dependent diabetes mellitus	0.010	0.990	0.000
E11.6 With other specified complications	0.009	0.991	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.009	0.991	0.000
E11.7 With multiple complications	0.008	0.992	0.000
K81.0 Acute cholecystitis	0.008	0.992	0.000
E11.9 Without complications	0.008	0.992	0.000
C44.1 Skin of eyelid, including canthus	0.007	0.993	0.000
E11.8 With unspecified complications	0.007	0.993	0.000
E11.2 With renal complications	0.007	0.993	0.000
E11.1 With ketoacidosis	0.007	0.993	0.000
N41.9 Inflammatory disease of prostate, unspecified	0.007	0.993	0.000
C44.5 Skin of trunk	0.007	0.993	0.000
C44.0 Skin of lip	0.007	0.993	0.000
C44 Other malignant neoplasms of skin	0.007	0.993	0.000
E11.0 With coma	0.006	0.993	0.000
O00-O08 Pregnancy with abortive outcome	0.006	0.994	0.000
H35.7 Separation of retinal layers	0.006	0.994	0.000
M19.90 Arthrosis, unspecified (Multiple sites)	0.000	0.994	0.006
O01 Hydatidiform mole	0.006	0.994	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.006	0.994	0.000
O07 Failed attempted abortion	0.005	0.994	0.000
F40.2 Specific (isolated) phobias	0.000	0.995	0.005
O64.0 Obstructed labour due to incomplete rotation of foetal head	0.000	0.995	0.005
N42 Other disorders of prostate	0.000	0.995	0.005
O01.9 Hydatidiform mole, unspecified	0.005	0.995	0.000
N28 Other disorders of kidney and ureter, not elsewhere classified	0.005	0.995	0.000
N41.0 Acute prostatitis	0.005	0.995	0.000
C44.8 Overlapping lesion of skin	0.005	0.995	0.000
O06 Unspecified abortion	0.005	0.995	0.000
O07.4 Failed medical abortion, without complication	0.005	0.995	0.000
K81 Cholecystitis	0.005	0.995	0.000
O05 Other abortion	0.005	0.995	0.000
H72.0 Central perforation of tympanic membrane	0.005	0.995	0.000
O08 Complications following abortion and ectopic and molar pregnancy	0.005	0.995	0.000
N41 Inflammatory diseases of prostate	0.005	0.995	0.000
K81.9 Cholecystitis, unspecified	0.005	0.995	0.000
O00 Ectopic pregnancy	0.005	0.995	0.000
C44.9 Malignant neoplasm of skin, unspecified	0.005	0.995	0.000
S60.8 Other superficial injuries of wrist and hand	0.005	0.995	0.000
D86.0 Sarcoidosis of lung	0.004	0.996	0.000
O01.1 Incomplete and partial hydatidiform mole	0.004	0.996	0.000
O01.0 Classical hydatidiform mole	0.004	0.996	0.000
N42.2 Atrophy of prostate	0.000	0.996	0.004
N28.0 Ischaemia and infarction of kidney	0.004	0.996	0.000
G71.0 Muscular dystrophy	0.004	0.996	0.000
K56.4 Other impaction of intestine	0.004	0.996	0.000
O07.9 Other and unspecified failed attempted abortion, without complication	0.004	0.996	0.000
O07.8 Other and unspecified failed attempted abortion, with other and unspecified complications	0.004	0.996	0.000
O07.7 Other and unspecified failed attempted abortion, complicated by embolism	0.004	0.996	0.000
O07.6 Other and unspecified failed attempted abortion, complicated by delayed or excessive haemorrhage	0.004	0.996	0.000
O07.5 Other and unspecified failed attempted abortion, complicated by genital tract and pelvic infection	0.004	0.996	0.000
O07.3 Failed medical abortion, with other and unspecified complications	0.004	0.996	0.000
O07.2 Failed medical abortion, complicated by embolism	0.004	0.996	0.000
O07.1 Failed medical abortion, complicated by delayed or excessive haemorrhage	0.004	0.996	0.000
O07.0 Failed medical abortion, complicated by genital tract and pelvic infection	0.004	0.996	0.000
D04.5 Skin of trunk	0.004	0.996	0.000
M13.95 Arthritis, unspecified (Pelvic region and thigh)	0.000	0.996	0.004
N41.8 Other inflammatory diseases of prostate	0.004	0.996	0.000
C44.7 Skin of lower limb, including hip	0.004	0.996	0.000
N12 Tubulo-interstitial nephritis, not specified as acute or chronic	0.004	0.996	0.000
E11.3 With ophthalmic complications	0.004	0.996	0.000
D04 Carcinoma in situ of skin	0.004	0.996	0.000
K74.0 Hepatic fibrosis	0.000	0.996	0.004
O00.1 Tubal pregnancy	0.004	0.996	0.000
O06.9 Complete or unspecified, without complication	0.004	0.996	0.000
D04.4 Skin of scalp and neck	0.004	0.996	0.000
N42.3 Dysplasia of prostate	0.000	0.996	0.004
O06.8 Complete or unspecified, with other and unspecified complications	0.004	0.996	0.000
O06.7 Complete or unspecified, complicated by embolism	0.004	0.996	0.000
O06.6 Complete or unspecified, complicated by delayed or excessive haemorrhage	0.004	0.996	0.000
O06.5 Complete or unspecified, complicated by genital tract and pelvic infection	0.004	0.996	0.000
O06.4 Incomplete, without complication	0.004	0.996	0.000
O06.3 Incomplete, with other and unspecified complications	0.004	0.996	0.000
O06.2 Incomplete, complicated by embolism	0.004	0.996	0.000
O06.1 Incomplete, complicated by delayed or excessive haemorrhage	0.004	0.996	0.000
O06.0 Incomplete, complicated by genital tract and pelvic infection	0.004	0.996	0.000
K81.1 Chronic cholecystitis	0.004	0.996	0.000
O05.9 Complete or unspecified, without complication	0.004	0.996	0.000
O05.8 Complete or unspecified, with other and unspecified complications	0.004	0.996	0.000
O05.7 Complete or unspecified, complicated by embolism	0.004	0.996	0.000
O05.6 Complete or unspecified, complicated by delayed or excessive haemorrhage	0.004	0.996	0.000
O05.5 Complete or unspecified, complicated by genital tract and pelvic infection	0.004	0.996	0.000
O05.4 Incomplete, without complication	0.004	0.996	0.000
O05.3 Incomplete, with other and unspecified complications	0.004	0.996	0.000
O05.2 Incomplete, complicated by embolism	0.004	0.996	0.000
O05.1 Incomplete, complicated by delayed or excessive haemorrhage	0.004	0.996	0.000
O05.0 Incomplete, complicated by genital tract and pelvic infection	0.004	0.996	0.000
N41.2 Abscess of prostate	0.004	0.996	0.000
N28.9 Disorder of kidney and ureter, unspecified	0.004	0.996	0.000
D04.6 Skin of upper limb, including shoulder	0.004	0.996	0.000
O08.9 Complication following abortion and ectopic and molar pregnancy, unspecified	0.003	0.996	0.000
O08.8 Other complications following abortion and ectopic and molar pregnancy	0.003	0.996	0.000
O08.7 Other venous complications following abortion and ectopic and molar pregnancy	0.003	0.996	0.000
O08.6 Damage to pelvic organs and tissues following abortion and ectopic and molar pregnancy	0.003	0.996	0.000
O08.5 Metabolic disorders following abortion and ectopic and molar pregnancy	0.003	0.996	0.000
O08.4 Renal failure following abortion and ectopic and molar pregnancy	0.003	0.996	0.000
O08.3 Shock following abortion and ectopic and molar pregnancy	0.003	0.996	0.000
O08.2 Embolism following abortion and ectopic and molar pregnancy	0.003	0.996	0.000
O08.0 Genital tract and pelvic infection following abortion and ectopic and molar pregnancy	0.003	0.996	0.000
D04.9 Skin, unspecified	0.004	0.996	0.000
E10.0 With coma	0.004	0.996	0.000
Z08.9 Follow-up examination after unspecified treatment for malignant neoplasm	0.000	0.996	0.004
O08.1 Delayed or excessive haemorrhage following abortion and ectopic and molar pregnancy	0.003	0.996	0.000
G71.1 Myotonic disorders	0.004	0.996	0.000
N41.3 Prostatocystitis	0.003	0.996	0.000
O00.8 Other ectopic pregnancy	0.003	0.996	0.000
O00.2 Ovarian pregnancy	0.003	0.996	0.000
O00.0 Abdominal pregnancy	0.003	0.996	0.000
G71 Primary disorders of muscles	0.004	0.996	0.000
K59.1 Functional diarrhoea	0.000	0.996	0.004
H92.1 Otorrhoea	0.003	0.996	0.000
D04.7 Skin of lower limb, including hip	0.003	0.997	0.000
E10-E14 Diabetes mellitus	0.003	0.997	0.000
D86 Sarcoidosis	0.003	0.997	0.000
K81.8 Other cholecystitis	0.003	0.997	0.000
S89.9 Unspecified injury of lower leg	0.000	0.997	0.003
D86.3 Sarcoidosis of skin	0.003	0.997	0.000
K74.5 Biliary cirrhosis, unspecified	0.000	0.997	0.003
K74 Fibrosis and cirrhosis of liver	0.000	0.997	0.003
D04.0 Skin of lip	0.003	0.997	0.000
E10.8 With unspecified complications	0.003	0.997	0.000
N28.1 Cyst of kidney, acquired	0.003	0.997	0.000
E78.9 Disorder of lipoprotein metabolism, unspecified	0.000	0.997	0.003
K74.3 Primary biliary cirrhosis	0.000	0.997	0.003
N42.1 Congestion and haemorrhage of prostate	0.000	0.997	0.003
D04.1 Skin of eyelid, including canthus	0.003	0.997	0.000
G71.3 Mitochondrial myopathy, not elsewhere classified	0.003	0.997	0.000
D04.2 Skin of ear and external auricular canal	0.003	0.997	0.000
K14 Diseases of tongue	0.000	0.997	0.003
D04.8 Skin of other sites	0.003	0.997	0.000
Z08.2 Follow-up examination after chemotherapy for malignant neoplasm	0.000	0.997	0.003
J10.1 Influenza with other respiratory manifestations, influenza virus identified	0.000	0.997	0.003
D86.9 Sarcoidosis, unspecified	0.003	0.997	0.000
N60.2 Fibroadenosis of breast	0.000	0.997	0.003
E10 Insulin-dependent diabetes mellitus	0.003	0.997	0.000
O64 Obstructed labour due to malposition and malpresentation of foetus	0.000	0.997	0.003
N42.0 Calculus of prostate	0.000	0.997	0.003
O64.1 Obstructed labour due to breech presentation	0.000	0.997	0.003
G71.9 Primary disorder of muscle, unspecified	0.003	0.997	0.000
G71.8 Other primary disorders of muscles	0.003	0.997	0.000
G71.2 Congenital myopathies	0.003	0.997	0.000
O02 Other abnormal products of conception	0.003	0.997	0.000
D03.6 Melanoma in situ of upper limb, including shoulder	0.003	0.997	0.000
D86.1 Sarcoidosis of lymph nodes	0.003	0.997	0.000
T14.9 Injury, unspecified	0.003	0.997	0.000
T86.0 Bone-marrow transplant rejection	0.000	0.997	0.003
K66.0 Peritoneal adhesions	0.003	0.997	0.000
O00.9 Ectopic pregnancy, unspecified	0.003	0.997	0.000
E12 Malnutrition-related diabetes mellitus	0.003	0.997	0.000
O03 Spontaneous abortion	0.003	0.997	0.000
K74.6 Other and unspecified cirrhosis of liver	0.000	0.997	0.003
M89.04 Algoneurodystrophy (Hand)	0.003	0.997	0.000
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.003	0.997	0.000
T14.1 Open wound of unspecified body region	0.003	0.997	0.000
K74.4 Secondary biliary cirrhosis	0.000	0.997	0.003
K74.2 Hepatic fibrosis with hepatic sclerosis	0.000	0.997	0.003
E13 Other specified diabetes mellitus	0.003	0.997	0.000
L53.9 Erythematous condition, unspecified	0.000	0.997	0.003
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.003	0.997	0.000
K14.5 Plicated tongue	0.000	0.997	0.002
K14.4 Atrophy of tongue papillae	0.000	0.997	0.002
K14.2 Median rhomboid glossitis	0.000	0.997	0.002
T14 Injury of unspecified body region	0.003	0.997	0.000
E10.3 With ophthalmic complications	0.003	0.997	0.000
K74.1 Hepatic sclerosis	0.000	0.997	0.002
E10.7 With multiple complications	0.002	0.998	0.000
M89.0 Algoneurodystrophy	0.002	0.998	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
O64.9 Obstructed labour due to malposition and malpresentation, unspecified	0.000	0.998	0.002
M89.06 Algoneurodystrophy (Lower leg)	0.002	0.998	0.000
E10.6 With other specified complications	0.002	0.998	0.000
O03.4 Incomplete, without complication	0.002	0.998	0.000
S22.10 Multiple fractures of thoracic spine (closed)	0.002	0.998	0.000
O64.5 Obstructed labour due to compound presentation	0.000	0.998	0.002
O64.4 Obstructed labour due to shoulder presentation	0.000	0.998	0.002
O64.3 Obstructed labour due to brow presentation	0.000	0.998	0.002
K14.0 Glossitis	0.000	0.998	0.002
O03.6 Complete or unspecified, complicated by delayed or excessive haemorrhage	0.002	0.998	0.000
S56.4 Injury of extensor muscle and tendon of other finger(s) at forearm level	0.000	0.998	0.002
O02.9 Abnormal product of conception, unspecified	0.002	0.998	0.000
O02.8 Other specified abnormal products of conception	0.002	0.998	0.000
T14.0 Superficial injury of unspecified body region	0.002	0.998	0.000
K14.3 Hypertrophy of tongue papillae	0.000	0.998	0.002
K14.6 Glossodynia	0.000	0.998	0.002
R07.0 Pain in throat	0.000	0.998	0.002
Y52 Agents primarily affecting the cardiovascular system	0.002	0.998	0.000
E12.9 Without complications	0.002	0.998	0.000
E12.8 With unspecified complications	0.002	0.998	0.000
E12.7 With multiple complications	0.002	0.998	0.000
E12.6 With other specified complications	0.002	0.998	0.000
E12.5 With peripheral circulatory complications	0.002	0.998	0.000
E12.4 With neurological complications	0.002	0.998	0.000
E12.3 With ophthalmic complications	0.002	0.998	0.000
E12.2 With renal complications	0.002	0.998	0.000
E12.1 With ketoacidosis	0.002	0.998	0.000
E12.0 With coma	0.002	0.998	0.000
O03.7 Complete or unspecified, complicated by embolism	0.002	0.998	0.000
O03.5 Complete or unspecified, complicated by genital tract and pelvic infection	0.002	0.998	0.000
O03.2 Incomplete, complicated by embolism	0.002	0.998	0.000
O03.0 Incomplete, complicated by genital tract and pelvic infection	0.002	0.998	0.000
Z29.0 Isolation	0.002	0.998	0.000
N10 Acute tubulo-interstitial nephritis	0.002	0.998	0.000
E10.4 With neurological complications	0.002	0.998	0.000
H73.8 Other specified disorders of tympanic membrane	0.000	0.998	0.002
K14.1 Geographic tongue	0.000	0.998	0.002
O64.2 Obstructed labour due to face presentation	0.000	0.998	0.002
M41.96 Scoliosis, unspecified (Lumbar region)	0.000	0.998	0.002
S06.40 Epidural haemorrhage (without open intracranial wound)	0.000	0.998	0.002
E13.3 With ophthalmic complications	0.002	0.998	0.000
M89.86 Other specified disorders of bone (Lower leg)	0.002	0.998	0.000
D03.5 Melanoma in situ of trunk	0.002	0.998	0.000
E13.8 With unspecified complications	0.002	0.998	0.000
E13.7 With multiple complications	0.002	0.998	0.000
E13.6 With other specified complications	0.002	0.998	0.000
E13.5 With peripheral circulatory complications	0.002	0.998	0.000
E13.4 With neurological complications	0.002	0.998	0.000
E13.2 With renal complications	0.002	0.998	0.000
E13.1 With ketoacidosis	0.002	0.998	0.000
E13.0 With coma	0.002	0.998	0.000
N87.0 Mild cervical dysplasia	0.002	0.998	0.000
O03.3 Incomplete, with other and unspecified complications	0.002	0.998	0.000
R22.9 Localised swelling, mass and lump, unspecified	0.000	0.998	0.002
T50.7 Analeptics and opioid receptor antagonists	0.002	0.998	0.000
T50.5 Appetite depressants	0.002	0.998	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
T50.1 Loop [high-ceiling] diuretics	0.002	0.998	0.000
T50.0 Mineralocorticoids and their antagonists	0.002	0.998	0.000
Z29.1 Prophylactic immunotherapy	0.002	0.998	0.000
M89.00 Algoneurodystrophy (Multiple sites)	0.002	0.998	0.000
E10.5 With peripheral circulatory complications	0.002	0.998	0.000
C71.9 Brain, unspecified	0.002	0.998	0.000
Q43.8 Other specified congenital malformations of intestine	0.002	0.998	0.000
T14.6 Injury of tendons and muscles of unspecified body region	0.002	0.998	0.000
O64.8 Obstructed labour due to other malposition and malpresentation	0.000	0.998	0.002
T14.2 Fracture of unspecified body region	0.002	0.998	0.000
T14.8 Other injuries of unspecified body region	0.002	0.998	0.000
T14.7 Crushing injury and traumatic amputation of unspecified body region	0.002	0.998	0.000
T14.5 Injury of blood vessel(s) of unspecified body region	0.002	0.998	0.000
T14.4 Injury of nerve(s) of unspecified body region	0.002	0.998	0.000
T14.3 Dislocation, sprain and strain of unspecified body region	0.002	0.998	0.000
T50.4 Drugs affecting uric acid metabolism	0.002	0.998	0.000
M89.03 Algoneurodystrophy (Forearm)	0.002	0.998	0.000
D86.8 Sarcoidosis of other and combined sites	0.002	0.998	0.000
D89.9 Disorder involving the immune mechanism, unspecified	0.002	0.998	0.000
G59.0 Diabetic mononeuropathy	0.002	0.998	0.000
M89.8 Other specified disorders of bone	0.002	0.998	0.000
O03.8 Complete or unspecified, with other and unspecified complications	0.002	0.998	0.000
O03.1 Incomplete, complicated by delayed or excessive haemorrhage	0.002	0.998	0.000
M89.08 Algoneurodystrophy (Other)	0.002	0.998	0.000
M89.05 Algoneurodystrophy (Pelvic region and thigh)	0.002	0.998	0.000
M89.02 Algoneurodystrophy (Upper arm)	0.002	0.998	0.000
M89.01 Algoneurodystrophy (Shoulder region)	0.002	0.998	0.000
T50.8 Diagnostic agents	0.002	0.998	0.000
Z36.1 Antenatal screening for raised alphafetoprotein level	0.002	0.998	0.000
M86.66 Other chronic osteomyelitis (Lower leg)	0.002	0.998	0.000
C79.7 Secondary malignant neoplasm of adrenal gland	0.002	0.998	0.000
N60.3 Fibrosclerosis of breast	0.000	0.998	0.002
Z83.3 Family history of diabetes mellitus	0.000	0.998	0.002
M80.00 Postmenopausal osteoporosis with pathological fracture (Multiple sites)	0.002	0.998	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
D80-D89 Certain disorders involving the immune mechanism	0.002	0.998	0.000
M89.87 Other specified disorders of bone (Ankle and foot)	0.002	0.998	0.000
N42.9 Disorder of prostate, unspecified	0.000	0.998	0.002
M89 Other disorders of bone	0.002	0.998	0.000
D72.1 Eosinophilia	0.002	0.998	0.000
M86.6 Other chronic osteomyelitis	0.002	0.998	0.000
N11.1 Chronic obstructive pyelonephritis	0.002	0.998	0.000
N13.9 Obstructive and reflux uropathy, unspecified	0.000	0.998	0.002
M80.98 Unspecified osteoporosis with pathological fracture (Other)	0.002	0.998	0.000
S60.9 Superficial injury of wrist and hand, unspecified	0.002	0.998	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
Y52.7 Peripheral vasodilators	0.002	0.998	0.000
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.002	0.998	0.000
M86.67 Other chronic osteomyelitis (Ankle and foot)	0.002	0.998	0.000
M89.09 Algoneurodystrophy (Site unspecified)	0.002	0.998	0.000
M89.84 Other specified disorders of bone (Hand)	0.002	0.998	0.000
E13.9 Without complications	0.002	0.998	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
Z82.0 Family history of epilepsy and other diseases of the nervous system	0.002	0.998	0.000
M89.07 Algoneurodystrophy (Ankle and foot)	0.002	0.998	0.000
G56.1 Other lesions of median nerve	0.000	0.998	0.002
K14.9 Disease of tongue, unspecified	0.000	0.998	0.002
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.002	0.998	0.000
N10-N16 Renal tubulo-interstitial diseases	0.002	0.998	0.000
M86.69 Other chronic osteomyelitis (Site unspecified)	0.002	0.998	0.000
Y52.1 Calcium-channel blockers	0.002	0.998	0.000
D32.0 Cerebral meninges	0.000	0.998	0.002
S02.80 Fractures of other skull and facial bones (closed)	0.002	0.998	0.000
E10.2 With renal complications	0.002	0.998	0.000
M89.4 Other hypertrophic osteo-arthropathy	0.002	0.998	0.000
N11 Chronic tubulo-interstitial nephritis	0.002	0.998	0.000
D75.8 Other specified diseases of blood and blood-forming organs	0.002	0.998	0.000
D03 Melanoma in situ	0.002	0.998	0.000
T14.21 Fracture of unspecified body region (open)	0.002	0.998	0.000
T14.20 Fracture of unspecified body region (closed)	0.002	0.998	0.000
H10.9 Conjunctivitis, unspecified	0.002	0.998	0.000
O02.0 Blighted ovum and nonhydatidiform mole	0.002	0.998	0.000
M89.83 Other specified disorders of bone (Forearm)	0.002	0.998	0.000
M89.82 Other specified disorders of bone (Upper arm)	0.002	0.998	0.000
M89.80 Other specified disorders of bone (Multiple sites)	0.002	0.998	0.000
Z29 Need for other prophylactic measures	0.002	0.998	0.000
N90.5 Atrophy of vulva	0.000	0.998	0.002
D84 Other immunodeficiencies	0.002	0.998	0.000
F40 Phobic anxiety disorders	0.000	0.998	0.002
M89.85 Other specified disorders of bone (Pelvic region and thigh)	0.002	0.998	0.000
D04.3 Skin of other and unspecified parts of face	0.002	0.998	0.000
D89.1 Cryoglobulinaemia	0.002	0.998	0.000
J30.1 Allergic rhinitis due to pollen	0.000	0.998	0.002
Z29.2 Other prophylactic chemotherapy	0.002	0.998	0.000
M89.40 Other hypertrophic osteoarthropathy (Multiple sites)	0.002	0.998	0.000
M89.81 Other specified disorders of bone (Shoulder region)	0.002	0.998	0.000
C45.9 Mesothelioma, unspecified	0.000	0.998	0.002
D03.1 Melanoma in situ of eyelid, including canthus	0.002	0.998	0.000
M89.3 Hypertrophy of bone	0.002	0.998	0.000
D81 Combined immunodeficiencies	0.002	0.998	0.000
M86.68 Other chronic osteomyelitis (Other)	0.002	0.998	0.000
M86.65 Other chronic osteomyelitis (Pelvic region and thigh)	0.002	0.998	0.000
M86.64 Other chronic osteomyelitis (Hand)	0.002	0.998	0.000
M86.63 Other chronic osteomyelitis (Forearm)	0.002	0.998	0.000
M86.62 Other chronic osteomyelitis (Upper arm)	0.002	0.998	0.000
M86.61 Other chronic osteomyelitis (Shoulder region)	0.002	0.998	0.000
M86.60 Other chronic osteomyelitis (Multiple sites)	0.002	0.998	0.000
M89.6 Osteopathy after poliomyelitis	0.002	0.998	0.000
M89.2 Other disorders of bone development and growth	0.002	0.998	0.000
M89.1 Epiphyseal arrest	0.002	0.998	0.000
E14 Unspecified diabetes mellitus	0.002	0.998	0.000
N25.9 Disorder resulting from impaired renal tubular function, unspecified	0.002	0.998	0.000
D83 Common variable immunodeficiency	0.002	0.998	0.000
Z08 Follow-up examination after treatment for malignant neoplasm	0.000	0.998	0.002
M89.89 Other specified disorders of bone (Site unspecified)	0.001	0.998	0.000
D89.3 Immune reconstitution syndrome	0.001	0.998	0.000
E14.6 With other specified complications	0.002	0.998	0.000
I71.3 Abdominal aortic aneurysm, ruptured	0.002	0.998	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
D03.0 Melanoma in situ of lip	0.002	0.998	0.000
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified	0.001	0.998	0.000
R52.0 Acute pain	0.002	0.998	0.000
W23.4 Street and highway	0.002	0.998	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
M62.65 Muscle strain (Pelvic region and thigh)	0.002	0.998	0.000
M86.87 Other osteomyelitis (Ankle and foot)	0.002	0.998	0.000
C71.1 Frontal lobe	0.002	0.998	0.000
D84.1 Defects in the complement system	0.001	0.998	0.000
D82 Immunodeficiency associated with other major defects	0.001	0.998	0.000
H92 Otalgia and effusion of ear	0.002	0.998	0.000
N16 Renal tubulo-interstitial disorders in diseases classified elsewhere	0.001	0.998	0.000
S89 Other and unspecified injuries of lower leg	0.000	0.998	0.002
N25-N29 Other disorders of kidney and ureter	0.002	0.998	0.000
D84.8 Other specified immunodeficiencies	0.001	0.998	0.000
N25 Disorders resulting from impaired renal tubular function	0.002	0.998	0.000
M24.11 Other articular cartilage disorders (Shoulder region)	0.002	0.998	0.000
M89.49 Other hypertrophic osteoarthropathy (Site unspecified)	0.001	0.998	0.000
M89.48 Other hypertrophic osteoarthropathy (Other)	0.001	0.998	0.000
M89.47 Other hypertrophic osteoarthropathy (Ankle and foot)	0.001	0.998	0.000
M89.46 Other hypertrophic osteoarthropathy (Lower leg)	0.001	0.998	0.000
M89.45 Other hypertrophic osteoarthropathy (Pelvic region and thigh)	0.001	0.998	0.000
M89.44 Other hypertrophic osteoarthropathy (Hand)	0.001	0.998	0.000
M89.43 Other hypertrophic osteoarthropathy (Forearm)	0.001	0.998	0.000
M89.42 Other hypertrophic osteoarthropathy (Upper arm)	0.001	0.998	0.000
M89.41 Other hypertrophic osteoarthropathy (Shoulder region)	0.001	0.998	0.000
N11.8 Other chronic tubulo-interstitial nephritis	0.001	0.998	0.000
M89.90 Disorder of bone, unspecified (Multiple sites)	0.001	0.998	0.000
D03.9 Melanoma in situ, unspecified	0.001	0.998	0.000
D03.8 Melanoma in situ of other sites	0.001	0.998	0.000
E14.1 With ketoacidosis	0.001	0.998	0.000
F40.9 Phobic anxiety disorder, unspecified	0.000	0.998	0.001
D80 Immunodeficiency with predominantly antibody defects	0.001	0.998	0.000
C78.7 Secondary malignant neoplasm of liver	0.002	0.998	0.000
D89.0 Polyclonal hypergammaglobulinaemia	0.001	0.998	0.000
M86.8 Other osteomyelitis	0.001	0.998	0.000
Q79.6 Ehlers-Danlos syndrome	0.001	0.998	0.000
Z29.9 Prophylactic measure, unspecified	0.001	0.998	0.000
M07.30 Other psoriatic arthropathies (Multiple sites)	0.002	0.998	0.000
F40.1 Social phobias	0.000	0.998	0.001
H92.0 Otalgia	0.002	0.998	0.000
I85.9 Oesophageal varices without bleeding	0.000	0.998	0.002
C71.4 Occipital lobe	0.001	0.998	0.000
D84.0 Lymphocyte function antigen-1 [LFA-1] defect	0.001	0.998	0.000
M89.9 Disorder of bone, unspecified	0.001	0.998	0.000
N11.0 Nonobstructive reflux-associated chronic pyelonephritis	0.001	0.998	0.000
M86 Osteomyelitis	0.001	0.998	0.000
S60 Superficial injury of wrist and hand	0.001	0.998	0.000
M89.39 Hypertrophy of bone (Site unspecified)	0.001	0.999	0.000
M89.37 Hypertrophy of bone (Ankle and foot)	0.001	0.999	0.000
M89.36 Hypertrophy of bone (Lower leg)	0.001	0.999	0.000
M89.35 Hypertrophy of bone (Pelvic region and thigh)	0.001	0.999	0.000
M89.34 Hypertrophy of bone (Hand)	0.001	0.999	0.000
M89.33 Hypertrophy of bone (Forearm)	0.001	0.999	0.000
M89.32 Hypertrophy of bone (Upper arm)	0.001	0.999	0.000
M89.31 Hypertrophy of bone (Shoulder region)	0.001	0.999	0.000
M89.30 Hypertrophy of bone (Multiple sites)	0.001	0.999	0.000
D80.9 Immunodeficiency with predominantly antibody defects, unspecified	0.001	0.999	0.000
D81.9 Combined immunodeficiency, unspecified	0.001	0.999	0.000
D81.8 Other combined immunodeficiencies	0.001	0.999	0.000
D81.7 Major histocompatibility complex class II deficiency	0.001	0.999	0.000
D81.6 Major histocompatibility complex class I deficiency	0.001	0.999	0.000
D81.5 Purine nucleoside phosphorylase [PNP] deficiency	0.001	0.999	0.000
D81.4 Nezelof's syndrome	0.001	0.999	0.000
D81.3 Adenosine deaminase [ADA] deficiency	0.001	0.999	0.000
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers	0.001	0.999	0.000
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers	0.001	0.999	0.000
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis	0.001	0.999	0.000
E14.4 With neurological complications	0.001	0.999	0.000
L53.8 Other specified erythematous conditions	0.000	0.999	0.001
N60 Benign mammary dysplasia	0.000	0.999	0.001
D00-D09 In situ neoplasms	0.001	0.999	0.000
M89.19 Epiphyseal arrest (Site unspecified)	0.001	0.999	0.000
M89.18 Epiphyseal arrest (Other)	0.001	0.999	0.000
M89.17 Epiphyseal arrest (Ankle and foot)	0.001	0.999	0.000
M89.16 Epiphyseal arrest (Lower leg)	0.001	0.999	0.000
M89.15 Epiphyseal arrest (Pelvic region and thigh)	0.001	0.999	0.000
M89.14 Epiphyseal arrest (Hand)	0.001	0.999	0.000
M89.13 Epiphyseal arrest (Forearm)	0.001	0.999	0.000
M89.12 Epiphyseal arrest (Upper arm)	0.001	0.999	0.000
M89.11 Epiphyseal arrest (Shoulder region)	0.001	0.999	0.000
M89.10 Epiphyseal arrest (Multiple sites)	0.001	0.999	0.000
M89.29 Other disorders of bone development and growth (Site unspecified)	0.001	0.999	0.000
M89.28 Other disorders of bone development and growth (Other)	0.001	0.999	0.000
M89.27 Other disorders of bone development and growth (Ankle and foot)	0.001	0.999	0.000
M89.26 Other disorders of bone development and growth (Lower leg)	0.001	0.999	0.000
M89.25 Other disorders of bone development and growth (Pelvic region and thigh)	0.001	0.999	0.000
M89.24 Other disorders of bone development and growth (Hand)	0.001	0.999	0.000
M89.23 Other disorders of bone development and growth (Forearm)	0.001	0.999	0.000
M89.22 Other disorders of bone development and growth (Upper arm)	0.001	0.999	0.000
M89.21 Other disorders of bone development and growth (Shoulder region)	0.001	0.999	0.000
M89.20 Other disorders of bone development and growth (Multiple sites)	0.001	0.999	0.000
M89.69 Osteopathy after poliomyelitis (Site unspecified)	0.001	0.999	0.000
M89.68 Osteopathy after poliomyelitis (Other)	0.001	0.999	0.000
M89.67 Osteopathy after poliomyelitis (Ankle and foot)	0.001	0.999	0.000
M89.66 Osteopathy after poliomyelitis (Lower leg)	0.001	0.999	0.000
M89.65 Osteopathy after poliomyelitis (Pelvic region and thigh)	0.001	0.999	0.000
M89.64 Osteopathy after poliomyelitis (Hand)	0.001	0.999	0.000
M89.63 Osteopathy after poliomyelitis (Forearm)	0.001	0.999	0.000
M89.62 Osteopathy after poliomyelitis (Upper arm)	0.001	0.999	0.000
M89.61 Osteopathy after poliomyelitis (Shoulder region)	0.001	0.999	0.000
M89.60 Osteopathy after poliomyelitis (Multiple sites)	0.001	0.999	0.000
E14.7 With multiple complications	0.001	0.999	0.000
E14.0 With coma	0.001	0.999	0.000
N41.1 Chronic prostatitis	0.001	0.999	0.000
Q38.7 Pharyngeal pouch	0.001	0.999	0.000
Z08.1 Follow-up examination after radiotherapy for malignant neoplasm	0.000	0.999	0.001
M89.38 Hypertrophy of bone (Other)	0.001	0.999	0.000
D83.8 Other common variable immunodeficiencies	0.001	0.999	0.000
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells	0.001	0.999	0.000
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders	0.001	0.999	0.000
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function	0.001	0.999	0.000
E14.8 With unspecified complications	0.001	0.999	0.000
R52.1 Chronic intractable pain	0.001	0.999	0.000
M86.85 Other osteomyelitis (Pelvic region and thigh)	0.001	0.999	0.000
D46.9 Myelodysplastic syndrome, unspecified	0.001	0.999	0.000
D82.9 Immunodeficiency associated with major defect, unspecified	0.001	0.999	0.000
D82.8 Immunodeficiency associated with other specified major defects	0.001	0.999	0.000
D82.4 Hyperimmunoglobulin E [IgE] syndrome	0.001	0.999	0.000
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus	0.001	0.999	0.000
D82.2 Immunodeficiency with short-limbed stature	0.001	0.999	0.000
D82.0 Wiskott-Aldrich syndrome	0.001	0.999	0.000
D89.2 Hypergammaglobulinaemia, unspecified	0.001	0.999	0.000
M89.5 Osteolysis	0.001	0.999	0.000
X49.9 Unspecified place	0.000	0.999	0.001
L53 Other erythematous conditions	0.000	0.999	0.001
M89.88 Other specified disorders of bone (Other)	0.001	0.999	0.000
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses	0.001	0.999	0.000
D80.2 Selective deficiency of immunoglobulin A [IgA]	0.001	0.999	0.000
E10.1 With ketoacidosis	0.001	0.999	0.000
N11.9 Chronic tubulo-interstitial nephritis, unspecified	0.001	0.999	0.000
N16.8 Renal tubulo-interstitial disorders in other diseases classified elsewhere	0.001	0.999	0.000
N16.5 Renal tubulo-interstitial disorders in transplant rejection	0.001	0.999	0.000
N16.4 Renal tubulo-interstitial disorders in systemic connective tissue disorders	0.001	0.999	0.000
N16.3 Renal tubulo-interstitial disorders in metabolic diseases	0.001	0.999	0.000
N16.2 Renal tubulo-interstitial disorders in blood diseases and disorders involving the immune mechanism	0.001	0.999	0.000
N16.1 Renal tubulo-interstitial disorders in neoplastic diseases	0.001	0.999	0.000
N16.0 Renal tubulo-interstitial disorders in infectious and parasitic diseases classified elsewhere	0.001	0.999	0.000
N60.4 Mammary duct ectasia	0.000	0.999	0.001
R70.0 Elevated erythrocyte sedimentation rate	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations